Premature Labor and Delivery - PowerPoint PPT Presentation

1 / 42
About This Presentation
Title:

Premature Labor and Delivery

Description:

Premature Labor and Delivery Honor M. Wolfe Associate Professor Maternal Fetal Medicine – PowerPoint PPT presentation

Number of Views:441
Avg rating:3.0/5.0
Slides: 43
Provided by: rex50
Category:

less

Transcript and Presenter's Notes

Title: Premature Labor and Delivery


1
Premature Labor and Delivery
  • Honor M. Wolfe
  • Associate Professor
  • Maternal Fetal Medicine

2
Objectives
  • To review the
  • Definition, frequency and consequence of preterm
    delivery
  • Modifiable and non modifiable risks for Preterm
    delivery
  • Pathogenesis of Preterm delivery
  • Prediction of Preterm delivery
  • Management of Preterm labor

3
Preterm Labor Definition
  • Regular uterine contractions
  • With
  • Cervical change or
  • gt 2 cm dilation or
  • gt 80 effacement

4
  • Preterm Delivery
  • - Preterm birthlt 37completed weeks
  • - Very Preterm birth lt 32 weeks
  • - Extremely Preterm birth lt 28 weeks

5
Incidence/Definitions
  • 12.5 USA (2004)
  • 2 lt 32 weeks
  • Fetal growth
  • Small for gestational age lt 10th for GA
  • Birthweight
  • Low BWT lt 2500 grams
  • Very low BWT lt 1500 grams
  • Extremely low BWT lt 1000 grams

6
Incidence
  • 13 Rise in PTB since 1992
  • Multiple gestation (20 increase)
  • 50 twins, 90 triplets born preterm
  • Changes in Obstetric management
  • Ultrasound, induction
  • Sociodemographic factors
  • AMA!
  • No improvement with physician interventions!

7
Leading Causes of Neonatal Death (USA)
  Neonatal deaths Percentage of neonatal deaths
Disorders related to prematurity and low birth weight 4,318 23.0
Congenital malformations, chromosomal abnormalities 4,144 22.1
Maternal complications 1,394 7.4
Placenta, cord, and membrane complications 1,049 5.6
Respiratory distress 929 4.9
Bacterial sepsis 737 3.9
Intrauterine hypoxia and birth asphyxia 589 3.1
Neonatal hemorrhage 563 3.0
Atelectasis 483 2.6
Necrotizing enterocolitis 313 1.7
Neonatal deaths death within 28 days of birth
.Data adapted from the Centers for Disease
Control and Prevention, 2000.
8
Significance
  • Infant mortality
  • Over 50 of infant deaths occur among the 1.5
    infants lt 1500 grams
  • 70 of infant deaths occur among the 7.7 of
    infants lt 2500 grams
  • Morbidity
  • 60 26 weeks
  • 30 30 weeks

9
(No Transcript)
10
(No Transcript)
11
(No Transcript)
12
Risk Factors for Preterm Birth
Non-modifiable
Prior preterm birth
African-American race
Age lt18 or gt40 years
Poor nutrition/low prepregnancy weight
Low socioeconomic status
Cervical injury or anomaly
Uterine anomaly or fibroid
Premature cervical dilatation (gt2 cm) or effacement (gt80 percent)
Over distended uterus (multiple pregnancy, polyhydramnios)
? Vaginal bleeding
? Excessive uterine activity

Modifiable Cigarette smoking
Substance abuse Absent prenatal care Short interpregnancy intervals Anemia Bacteriuria/urinary tract infection
Genital infection ? Strenuous work
? High personal stress






13
Risk factors for preterm birth
  • Stress
  • Single women
  • Low socioeconomic status
  • Anxiety
  • Depression
  • Life events (divorce, separation, death)
  • Abdominal surgery during pregnancy
  • Occupational fatigue
  • Upright posture
  • Use of industrial machines
  • Physical exertion
  • Mental or environmental stress
  • Excessive or impaired uterine distention
  • Multiple gestation
  • Polyhydramnios
  • Uterine anomaly or fibroids
  • Diethystilbesterol
  • Cervical factors
  • History of second trimester abortion
  • History of cervical surgery
  • Premature cervical dilatation or effacement
  • Infection
  • Sexually transmitted infections
  • Pyelonephritis
  • Systemic infection
  • Bacteriuria
  • Periodontal disease
  • Placental pathology
  • Placenta previa
  • Abruption
  • Vaginal bleeding

14
Risk factors for preterm birth
  • Miscellaneous
  • Previous preterm delivery
  • Substance abuse
  • Smoking
  • Maternal age (lt18 or gt40)
  • African-American race
  • Poor nutrition and low body mass index
  • Inadequate prenatal care
  • Anemia (hemoglobin lt10 g/dL)
  • Excessive uterine contractility
  • Low level of educational achievement
  • Genotype
  • Fetal factors
  • Congenital anomaly
  • Growth restriction

15
Prior preterm birth
  • Increases risk in subsequent pregnancy
  • Risk increases with
  • more prior preterm births
  • earlier GA of prior preterm birth (s)

16
Prediction/Recurrence
  • Prior PTD _at_ (23-27 wks) 27
  • Prior PPROM 13.5

17
(No Transcript)
18
Pathogenesis
  • 80 of Preterm births are spontaneous
  • 50 Preterm labor
  • 30 Preterm premature rupture of the membranes
  • Pathogenic processes
  • Activation of the maternal or fetal hypothalamic
    pituitary axis
  • Infection
  • Decidual hemorrhage
  • Pathologic uterine distention

19
Activation of the HPA Axis
  • Premature activation
  • Major maternal physical/psychologic stress
  • Stress of uteroplacental vasculopathy
  • Mechanism
  • Increased Corticotropin-releasing hormone
  • Fetal ACTH
  • Estrogens (incr myometrial gap junctions)

20
Inflammation
  • Clinical/subclinical chorioamnionitis
  • Up to 50 of preterm birth lt 30 wks GA
  • Proinflammatory mediators
  • maternal/fetal inflammatory response
  • Activated neutrophils/macrophages
  • TNF alpha, interleukins (6)
  • Bacteria
  • Degradation of fetal membranes
  • Prostaglandin synthesis

21
Prediction of Preterm Delivery
  • History Current and Historical Risk Factors
  • Mechanical
  • Uterine contractions
  • Home uterine activity monitoring
  • Biochemical
  • Fetal fibronectin
  • Ultrasound
  • Cervical length

22
Fetal fibronectin-
  • Glycoprotein in amnion, decidua,
  • cytotrophoblast
  • Increased levels secondary to breakdown of
    the chorionic-decidual interface
  • Inflammation, shear, movement

23
Fetal fibronectin as a predictor for delivery
within 7 and 14 days after sampling, combined
results
  • Delivery lt7 days
    Delivery lt14 days
  • Sensitivity Specificity
    Sensitivity Specificity
  • (percent), (percent), 95
    (percent), 95 (percent), 95
  • 95 percent CI percent CI
    percent CI percent CI
  • Study group
  • All studies 71 (57-84) 89
    (84-93) 67 (51-82) 89
    (85-94)
  • Women with
  • preterm labor 77 (67-88) 87
    (84-91) 74 (67-82) . 87
    (83-92)
  • Asymptomatic 63 (26-90) 97 (97-98)
    51 (33-70) . 96 (92-100)
  • (low risk or
  • high-risk)
  • women
  • CI confidence interval. Only one study
    included in analysis.
  • . Fixed-effects model used (homogeneity
    test P gt0.10).Data from Leitich, H, Kaider, A.
    Fetal fibronectin - how useful is it in the
    prediction of preterm birth? BJOG 2003 110
    (Suppl 20)66.

24
Fetal fibronectin vs. Clinical assessment of
Preterm Labor
  • Parameter Sensitivity (percent) PPV
    (percent) NPV (percent)
  • Fetal fibronectin 93
    29
    99
  • Cervical
  • dilatation gt1 cm 29
    11
    94
  • Contraction
  • frequency 8/h 42
    9
    94
  • PPV positive predictive value NPV negative
    predictive value. Data derived from
    symptomatic women and reflect the ability to
    predict delivery within
  • seven days. Adapted from Iams, JD,
    Casal, D, McGregor, JA, et al. Am J Obstet
    Gynecol 1995
  • 173141.

25
Sonographic assessment of cervical
length - Transvaginal - Reproducible -
Simple
26
  • (Dijkstra et al Am J Obstet Gynecol 1999)

27
(No Transcript)
28
(No Transcript)
29
(No Transcript)
30
Assessment of Risk
  • Integration of
  • History,
  • Cervical length
  • Fibronectin

31
Prediction of spontaneous preterm delivery
before 35 weeks gestation among asymptomatic low
risk women
  • Cervical length
    Fetal fibronectin Both tests
  • lt25mm (percent)
    (percent) (percent)
  • Positive test
  • Result 8.5
    3.6
    0.5
  • Sensitivity 39
    23
    16
  • Specificity 92.5
    97
    99.5
  • Positive predictive
  • Value 14
    20
    50
  • Negative predictive
  • value 98
    98
    94.4
  • Adapted from Iams, JD, Goldenberg, RL, Mercer,
    BM, et al. Am J Obstet Gynecol 2001 184652.

32
Risk of Preterm birth lt 35 weeks
History of Delivery 18-26 27-31 32-36 gt 37

FFN (-)
CL lt 25 25 25 25 6
CL 26-35 14 14 13 3
CL gt 35 7 7 7 1

FFN ()
CL lt 25 64 64 63 25
CL 26-35 46 45 45 14
CL gt 35 28 28 27 7
33
Clinical Diagnosis Preterm Labor
  • Clinical Criteria
  • Persistent Ctx 4 q 20 min or 8 q 60 min
  • Cervical change/80 effacement/gt 2cm dil.
  • Among the most common admission Dx
  • Inexact diagnosis PTL is not PTD
  • 30 PTL resolves spontaneously
  • 50 of hospitalized PTL deliver _at_ term

34
Management of Preterm Labor
  • Bedrest, hydration, sedation
  • NO evidence to support in the literature

35
Beta adrenergic receptor agonists (terbutaline)
  • Mechanism
  • Interferes w/ myosin light chain kinase
  • Inhibits actin myosin interaction
  • Efficacy
  • ? 48 hours. No change in perinatal outcome
  • Side Effects
  • Tachycardia, palpitations,hypotension,SOB,
    pulmonary edema, hyperglycemia
  • Contraindications
  • Maternal cardiac disease, uncontrolled diabetes
    and hyperthyroidism

36
Magnesium Sulfate
  • Mechanism of Action
  • Competes with Calcium at plasma memb (?)
  • Efficacy
  • Unproven
  • Side Effects
  • Diaphoresis, flushing, pulmonary edema
  • Contraindications
  • Myasthesthenia gravis, renal failure

37
Calcium Channel Blockers
  • Mechanism of Action
  • Directly block influx of Ca thru cell membrane
  • Efficacy
  • Unproven
  • Side Effects
  • Nausea, flushing, HA, palpitations
  • Contraindications
  • Caution LV dysfunction, CHF

38
Cyclooxygenase Inhibitors
  • Mechanism of Action
  • Decrease prostaglandin production
  • Efficacy
  • Unproven
  • Side Effects
  • Nausea, GI reflux, spasm fetal DA, oligo
  • Contraindications
  • Platelet or hepatic dysfunction, GI ulcer
  • Renal dysfunction, asthma

39
Antenatal Steroids
  • Recommended for
  • Preterm labor 24 34 weeks
  • PPROM 24 32 weeks
  • Reduction in
  • Mortality, IVH, NEC, RDS
  • Mechanism of action
  • Enhanced maturation lungs
  • Biochemical maturation

40
Antenatal Steroids
  • Dosage
  • Dexamethasone 6 mg q 12 h
  • Betamethasone 12.5 mg q 24 h
  • Repeated doses - NO
  • Effect
  • Within several hours
  • Max _at_ 48 hours

41
Progesterone for History of PTB
  • 17 alpha OH Progesterone
  • Women with prior PTB (singleton) 24 26 wks
  • (16 20 wks) 36 weeks
  • Reduces the risk of recurrent preterm birth
  • lt 37 wks 36 vs 55
  • lt 35 wks 21 vs 31
  • lt 32 wks 11 vs 20

42
Case 1
  • A 36 year old black female G2 P 0101 presents at
    8 weeks gestation.
  • History Chronic hypertension, no meds
  • Smokes 1 ppd, Drugs (-) ETOH ()
  • STI history of chlamydia, HIV positive
  • Surgical history LEEP, tubal ligation
Write a Comment
User Comments (0)
About PowerShow.com